Aditi Bhaduri, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2510 Douglas Blvd Ste 300, Roseville, CA 95661 Phone: 916-746-2343 |
Dr. Sallie O Adams, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3100 Douglas Blvd, Sutie 204, Roseville, CA 95661 Phone: 916-774-8885 Fax: 916-774-8818 |
Jagmeet Mangat, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3100 Douglas Blvd, Roseville, CA 95661 Phone: 916-774-8384 Fax: 916-774-8327 |
Matthew H. Connors, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 |
Richa Bhattarai, M.D Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4004 |
Dr. Nandi Mukesh Shah, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 |
Jose Joaquin Lado-abeal, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1620 E Roseville Pkwy Ste 200, Roseville, CA 95661 Phone: 916-783-7109 |
Jodi Beth Nagelberg, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3400 Douglas Blvd Ste 225, Roseville, CA 95661 Phone: 916-746-2343 |
Michael C. Okimura, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Mob 1, Building D, Roseville, CA 95661 Phone: 916-784-4004 |
Manish R Upadhyay, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 508 Gibson Dr Ste 270, Roseville, CA 95678 Phone: 916-786-6727 |
News Archive
Teva Pharmaceutical Industries Ltd. announces that the FDA has decided that its wholly owned subsidiary, Teva Pharmaceuticals USA, is sole first-to-file for both Orange Book patents listed for Provigil (modafinil) and therefore Teva's ANDA alone is entitled to 180-day exclusivity.
Six physician organizations in the Sutter Medical Network, including all five medical foundations, received "Elite" status today in the annual CAPG Standards of Excellence Survey—the highest possible honor awarded by the CAPG professional organization.
ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
› Verified 6 days ago